Personalized Medicine and Intellectual Property Conference
- Starts: 9:00 am on Monday, August 25, 2014
- Ends: 5:00 pm on Monday, August 25, 2014
In the wake of recent U.S. Supreme Court rulings that found that the human gene BRCA (which produces tumor suppression proteins) and a diagnostic test for Vitamin B deficiency were not inventions that could be patented, BU Law is hosting this conference to examine the potential impact of these rulings on medical research by private companies. The Kauffman Foundation is funding the conference, which will bring together legal, business and economic experts to weigh in on the after-effects of the Prometheus and Mryiad rulings. The event is open to the public.
- Redstone Building, Room 101